ALDH3A2 INHIBITION AND FERROPTOSIS INDUCTION FOR CANCER THERAPY
Disclosed herein are methods and compositions for inhibiting Aldh3a2 expression and activity to improve leukemia outcomes. Aldh3a2 depletion results in iron-dependent oxidative cell death of leukemia cells while sparing normal hematopoiesis.